From skin to mind: the psychological consequences of psoriasis severity and approaches to coping

Sahil Kapur; Sajan Shah; Akshay Reddy; Kermanjot Sidhu; Kabir D. Kapur; Sanjay Satya-Akunuri Koka; Mark Houdi; Craig G. Burkhart

doi:10.18203/issn.2455-4529.IntJResDermatol20252558

Authors

Sahil Kapur Department of Medicine, Division of Dermatology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA
Sajan Shah University of Toledo, Ohio, USA
Akshay Reddy Nova Southeastern University, Fort Lauderdale, FL, USA
Kermanjot Sidhu College of Human Medicine, Michigan State University, East Lansing, MI, USA
Kabir D. Kapur Department of Precision Medicine, Precision Pundits, Northville, MI, USA
Sanjay Satya-Akunuri Koka Department of Medicine, Division of Dermatology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA
Mark Houdi Department of Medicine, Division of Dermatology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA
Craig G. Burkhart Department of Medicine, Division of Dermatology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20252558

Keywords:

Psoriasis, Psychological distress, Anxiety, Depression, Quality of life, Cognitive behavioral therapy, Mindfulness-based therapy, Interdisciplinary approach, Salford psoriasis index, Dermatology quality of life index

Abstract

Psoriasis is a chronic, systemic, inflammatory skin condition that causes red, scaly, and pruritic lesions. Psoriasis can be detrimental to both physical and mental health. The worsening of psoriasis is caused by mental stress, especially depression and anxiety. Approximately 34% of patients with psoriasis exhibit signs of anxiety. Symptoms of anxiety are present in about 34% of patients with psoriasis. Studies reveal that 15% of patients meet the diagnosis for social anxiety disorder, 11% for generalized anxiety disorder, and 9% for unspecified anxiety disorder. Higher rates of depression and anxiety are observed among patients with severe psoriasis compared to those with less severe psoriasis. Psychosocial distress and higher levels of anxiety and depression scores are noted in women and younger patients. The Salford psoriasis index (SPI) and dermatology quality of life index (DQL) are good measures to evaluate the severity of the disease and quality of life (QoL), respectively. Both these indices confirm an inverse relationship between the severity of psoriasis and a decrease in mental health. Psoriasis requires a multidisciplinary plan to treat both psoriasis and the associated mental health conditions. There is evidence-based data for the effectiveness of cognitive-behavioral therapy (CBT) and mindfulness-based therapies in the treatment of psoriasis patients. Having a comprehensive treatment approach to treat psoriasis and mental illness simultaneously may lead to improved patient outcomes and QoL.

Metrics

Metrics Loading ...

References

Tseng JC, Chang YC, Huang CM, Hsu LC, Chuang TH. Therapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis. Pharmaceutics. 2021;13(7):1064. DOI: https://doi.org/10.3390/pharmaceutics13071064

Bhagwat AP, Madke B. The Current Advancement in Psoriasis. Cureus. 2023;15(10):e47006. DOI: https://doi.org/10.7759/cureus.47006

Eghlileb AM, Davies EE, Finlay AY. Psoriasis has a major secondary impact on the lives of family members and partners. Brit J Dermatol. 2007;156(6):1245-50. DOI: https://doi.org/10.1111/j.1365-2133.2007.07881.x

Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. The Lancet. 2007;370(9583):263-71. DOI: https://doi.org/10.1016/S0140-6736(07)61128-3

Jalenques I, Bourlot F, Martinez E, Pereira B, D'Incan M, Lauron S. Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysis. Acta Dermato-Venereologica. 2022;102(2):1386. DOI: https://doi.org/10.2340/actadv.v102.1386

Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383-92. DOI: https://doi.org/10.2165/00128071-200506060-00005

Magin P, Adams J, Heading G, Pond D, Smith W. The psychological sequelae of psoriasis: results of a qualitative study. Psychol Heal Med. 2009;14(2):150-61. DOI: https://doi.org/10.1080/13548500802512294

Snast I, Reiter O, Atzmony L, Leshem YA, Hodak E, Mimouni D, Pavlovsky L. Psychological stress and psoriasis: a systematic review and meta-analysis. Brit J Dermatol. 2018;178(5):1044-55.

Remröd C, Berg J, Linder E. Subjective stress reactivity in psoriasis-a cross-sectional study. BMC Dermatol. 2015;15(2):1-8.

Prignano F, Campione E, Parodi A, Vegni E, Bardazzi F, Borroni RG, et al. EMPATHY Life in Psoriasis: Embracing Patients' Well-Being in Their Journey of Moderate-to-Severe Psoriasis. J Clin Med. 2024;13(15):4469. DOI: https://doi.org/10.3390/jcm13154469

Ferreira BI, Abreu JL, Reis JP, Figueiredo AM. Psoriasis and Associated Psychiatric Disorders: A Systematic Review on Etiopathogenesis and Clinical Correlation. J Clin Aesthet Dermatol. 2016;9(6):36-43.

Snast I, Reiter O, Atzmony L, Leshem YA, Hodak E, Mimouni D, et al. Psychological stress and psoriasis: a systematic review and meta-analysis. Brit J Dermatol. 2018;178(5):1044-55. DOI: https://doi.org/10.1111/bjd.16116

Remröd C, Berg J, Linder E. Subjective stress reactivity in psoriasis-a cross-sectional study. BMC Dermatol. 2015;15(2):1-8. DOI: https://doi.org/10.1186/s12895-015-0026-x

Homayoon D, Hiebler-Ragger M, Zenker M, Weger W, Unterrainer H, Aberer E. Relationship Between Skin Shame, Psychological Distress and Quality of Life in Patients with Psoriasis: A Pilot Study. Acta Dermato-Venereolog. 2020;100(14):1-6. DOI: https://doi.org/10.2340/00015555-3563

Luna PC, Chu CY, Fatani M, Borlenghi C, Adora A, Llamado LQ, et al. Psychosocial burden of psoriasis: A systematic literature review of depression among patients with psoriasis. Dermatol Therapy. 2023;13:3043-55. DOI: https://doi.org/10.1007/s13555-023-01060-5

Payne RA, Rowland Payne CM, Marks R. Stress does not worsen psoriasis? a controlled study of 32 patients. Clin Exp Dermatol. 1985;10(3):239-45. DOI: https://doi.org/10.1111/j.1365-2230.1985.tb00564.x

Cipolla S, Catapano P, Bonamico AF, De Santis V, Murolo R, Romano F, et al. Factors Associated with Anxiety, Depression, and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study. Brain Sci. 2024;14(9):865. DOI: https://doi.org/10.3390/brainsci14090865

Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891-5. DOI: https://doi.org/10.1001/archdermatol.2010.186

Sahi FM, Masood A, Danawar NA, Mekaiel A, Malik BH. Association Between Psoriasis and Depression: A Traditional Review. Cureus. 2020;12(8):e9708. DOI: https://doi.org/10.7759/cureus.9708

Krstanović K, Kroflin K, Kroflin L, Kušević Z. Psoriasis and mental health: A psychodermatological approach with an emphasis on psychotherapy. Psychiatria Danubina, 36(1), 7-16. DOI: https://doi.org/10.24869/psyd.2024.7

Costeris C, Petridou M, Ioannou Y. Body image, self-esteem, and quality of life in patients with psoriasis. Dermatol Therapy. 2023;13:3043-55.

Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Quality Life Outcomes. 2006;4:35. DOI: https://doi.org/10.1186/1477-7525-4-35

Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Academy Dermatol. 2004;51(5):704-8. DOI: https://doi.org/10.1016/j.jaad.2004.04.014

Dakanalis A, Mentzelou M, Papadopoulou SK, Papandreou D, Spanoudaki M, Vasios GK, et al. The Association of Emotional Eating with Overweight/Obesity, Depression, Anxiety/Stress, and Dietary Patterns: A Review of the Current Clinical Evidence. Nutrients. 2023;15(5):1173. DOI: https://doi.org/10.3390/nu15051173

Wojtyna E, Łakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezińska-Wcisło L. Gender, Body Image and Social Support: Biopsychosocial Determinants of Depression Among Patients with Psoriasis. Acta Dermato-Venereol. 2017;97(1):91-7. DOI: https://doi.org/10.2340/00015555-2483

Curcio C, Corboy D. Stigma and anxiety disorders: A systematic review. Stigma Health. 2020;5(2):125-37. DOI: https://doi.org/10.1037/sah0000183

Eylem O, de Wit L, van Straten A, Steubl L, Melissourgaki Z, Danışman GT, et al. Stigma for common mental disorders in racial minorities and majorities a systematic review and meta-analysis. BMC Publ Heal. 2020;20(1):879. DOI: https://doi.org/10.1186/s12889-020-08964-3

Matthewman J, Mansfield KE, Hayes JF, Adesanya EI, Smith CH, Roberts A, et al. Anxiety and Depression in People with Eczema or 29. Psoriasis: A Comparison of Associations in UK Biobank and Linked Primary Care Data. Clin Epidemiol. 2023;15:285-95. DOI: https://doi.org/10.2147/CLEP.S417176

Lim DS, Bewley A, Oon HH. Psychological Profile of Patients with Psoriasis. Ann Academy Med Singapore. 2018;47(12):516-22. DOI: https://doi.org/10.47102/annals-acadmedsg.V47N12p516

Fortune DG, Richards HL, Kirby B, Bowcock S, Main CJ, Griffiths CE. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Brit J Dermatol. 2002;146(3):458-65. DOI: https://doi.org/10.1046/j.1365-2133.2002.04622.x

Wei W, Zhang B, Liu T, Lu T. Effect of Psychological Intervention on Quality of Life Among Patients with Psoriasis: A Meta-analysis. Int J Behav Med. 2024;31(3):123-35. DOI: https://doi.org/10.1007/s12529-024-10315-0

Qureshi AA, Awosika O, Baruffi F, Rengifo-Pardo M, Ehrlich A. Psychological Therapies in Management of Psoriatic Skin Disease: A Systematic Review. Am J Clin Dermatol. 2019;20(4):607-24. DOI: https://doi.org/10.1007/s40257-019-00437-7

Frances S, Shawyer F, Cayoun B, Enticott J, Meadows G. Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients. BMC Psychiatr. 2020;20(1):7. DOI: https://doi.org/10.1186/s12888-019-2411-1

Oster A. Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis. Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 52-Week Results from the KEEPsAKE 2 Study. 2022. Available at: academic.oup.com/rheumatology /article/62/6/2122/6772503. Accessed on 12 June 2025. DOI: https://doi.org/10.1093/rheumatology/keac605

Burshtein J. The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel. Dermatology and Therapy, U.S. National Library of Medicine. 2024. DOI: https://doi.org/10.1007/s13555-024-01099-y

Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consulting Clin Psychol. 2010;78(2):169-83. DOI: https://doi.org/10.1037/a0018555

Schmitt J, Wozel G, Garzarolli M, Viehweg A, Bauer M, Leopold K. Effectiveness of interdisciplinary vs. dermatological care of moderate-to-severe psoriasis: a pragmatic randomised controlled trial. Acta dermato-venereol. 2014;94(2):192-7. DOI: https://doi.org/10.2340/00015555-1697